Can You Get Weight Loss Injections Free on the NHS?

NHS England is rolling out tirzepatide (Mounjaro) in phases from June 2025, starting with the most complex cases; Wegovy (semaglutide) is available via specialist weight management services under separate NICE guidance.
Both medicines are prescription-only and require a clinical assessment — BMI alone does not determine access.
NHS criteria are strict and phased; many people turn to regulated private services while they wait or if they do not meet the current thresholds.
Private prescriptions from a GPhC-registered pharmacy include a full clinical consultation and are subject to the same safety standards as NHS prescribing.

Weight loss injections are available free on the NHS in England, but access is tightly controlled and phased in over several years. Eligibility depends on your BMI, how many specific health conditions you have, and whether your local area has activated the current rollout cohort. Most people asking this question right now will not yet qualify — and if they do, the waiting list can be long. These medicines are prescription-only, and a prescriber assesses whether they are clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How NHS access to weight loss injections actually works in 2025 and 2026

You've looked it up, found conflicting answers, and you're not sure where you stand

If you've spent twenty minutes reading different websites and still aren't certain whether you can get weight loss injections on the NHS, that's understandable, the rollout is genuinely complicated, and it is changing by cohort every few months. The honest answer is that free access exists, but it is rationed carefully and moving slowly.

NHS England is phasing in tirzepatide (Mounjaro) for weight management under NICE technology appraisal TA1026, published in December 2024. The first cohort, active from June 2025, requires a BMI of 40 or above plus four or more of five specific conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. A second cohort covering BMI 35–39.9 with four or more of those conditions was activated on 23 June 2026. Further cohorts will follow, expanding eligibility as NHS capacity grows. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, typically 2.5 kg/m² below the figures above.

Separately, Wegovy (semaglutide) is available through specialist weight management services under NICE guidance TA875. That route is limited to people already in, or referred to, a multidisciplinary specialist service, and waiting lists in most areas stretch to many months. You can read more about how NHS weight loss injections are commissioned and what the referral pathway looks like.

Why the criteria are so strict right now

NICE and NHS England built the phased rollout around clinical need and NHS capacity. The cost of treatment, the requirement for dietary and activity support alongside prescribing, and the scale of demand all factor into why the early cohorts are restricted to people with the highest clinical complexity.

GP practices can prescribe under the 2026/27 GP contract, but participation is optional, so availability varies by practice even within the same area. Meeting the national criteria does not guarantee your surgery is currently offering the service. NHS England is explicit on this point in its weight management injections guidance: every patient must also be enrolled in wrap-around diet and lifestyle support, which takes capacity to deliver.

For people with a BMI of 35 or above and relevant conditions who are not yet in a qualifying cohort, or whose GP practice has not yet activated the service, the wait is real. That is the situation many people searching this question are actually in, not failing to understand the rules, but genuinely caught between eligibility on paper and access in practice.

If you want to understand what the current thresholds look like in detail, the new NHS weight loss injection criteria page sets them out cohort by cohort. You can also find a detailed breakdown of how the NHS weight loss injection programme works, including which services are involved and what the prescription process looks like in practice.

What the private route offers while you wait, or if you don't qualify yet

Private prescribing of tirzepatide and semaglutide follows the licensed eligibility in the medicines' SmPCs: adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as prediabetes, hypertension, high cholesterol, or obstructive sleep apnoea. The clinical bar is lower than the NHS's complex-case criteria, though it is still a clinical bar, a prescriber reviews every case individually.

At nume, that review happens the same day. A GPhC-registered Independent Prescriber reads your consultation, not a piece of software. There is no referral form to fill in and no waiting list between clinical approval and dispatch, orders placed before 12pm on a weekday are sent out the same day, delivered free by DPD the next working day in plain packaging. For context on what private treatment costs and what is included in the price, see our weight loss injection cost guide.

The service includes free aftercare seven days a week and a clinical re-review before every repeat order. There are no subscriptions and no automatic renewals. Our clinical team operates within the same MHRA-regulated supply chain as any NHS-contracted pharmacy, the medicines are the same; the route to them is different.

If you want to explore whether private treatment through a GPhC-registered pharmacy might suit you, the weight loss injections overview explains both medicines, their evidence base, and the consultation process. You can also review the broader weight loss treatment options available through nume before deciding anything.

These are prescription-only medicines. A prescriber decides suitability. Speak to our prescribers to find out whether you are eligible through the private route.

Start your free consultation with our prescribers

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions